Log In
Print
BCIQ
Print
Print this Print this
 

Ampyra, Fampyra fampridine, dalfampridine (BIIB041)

Also known as: Fampridine-SR, Fampyra, fampridine (formerly Amaya, Fampridine-PR, Neurelan)

  Manage Alerts
Collapse Summary General Information
Company Alkermes plc
DescriptionSustained-release formulation of 4-aminopyridine (4-AP)
Molecular Target Potassium channel
Mechanism of ActionK channel blocker
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today